Transcutaneous Oxygen Monitoring
- 1 March 1985
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 139 (3) , 288-291
- https://doi.org/10.1001/archpedi.1985.02140050082029
Abstract
• To validate transcutaneous Po2 (TcPo2) monitoring for outpatient use in cyanotic congenital heart disease (CCHD), TcPo2 was compared with simultaneous arterial Po2 at cardiac catheterization and with arterial Po2 obtained by puncture. Over a 40-month period, 1,493 outpatient TcPo2 determinations were made in 461 patients to diagnose the presence or absence of hypoxemia in newly referred patients and to help assess oxygen delivery in patients with known CCHD. Clinical decisions regarding the need for further diagnostic study and the adequacy of oxygen delivery were made based on these determinations. (AJDC 1985;139:288-291)This publication has 5 references indexed in Scilit:
- Transcutaneous PO2 monitoring in infants with cyanotic congenital heart disease treated with prostaglandin E1Pediatric Cardiology, 1983
- Theoretical basis of the transcutaneous blood gas measurementsCritical Care Medicine, 1981
- Noninvasive Transcutaneous Oxygen Pressure Diagnosis of Reversed Ductal Shunts in Cyanotic Heart DiseasePediatrics, 1980
- Clinical Limitations and Advantages of Transcutaneous Oxygen ElectrodesActa Anaesthesiologica Scandinavica, 1978
- Reliability of transcutaneous monitoring of arterial Po2 in newborn infantsArchives of Disease in Childhood, 1974